Presentation is loading. Please wait.

Presentation is loading. Please wait.

Risk Factors Associated With Reoperation and Mortality in 252 Patients After Aortic Valve Replacement for Congenitally Bicuspid Aortic Valve Disease 

Published byRené Fortin Modified over 6 years ago

Similar presentations

Presentation on theme: "Risk Factors Associated With Reoperation and Mortality in 252 Patients After Aortic Valve Replacement for Congenitally Bicuspid Aortic Valve Disease "— Presentation transcript:

1 Risk Factors Associated With Reoperation and Mortality in 252 Patients After Aortic Valve Replacement for Congenitally Bicuspid Aortic Valve Disease  Sorel Goland, MD, Lawrence S.C. Czer, MD, Michele A. De Robertis, RN, James Mirocha, MS, Robert M. Kass, MD, Gregory P. Fontana, MD, Wen Chang, MD, Alfredo Trento, MD  The Annals of Thoracic Surgery  Volume 83, Issue 3, Pages (March 2007) DOI: /j.athoracsur Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Survival of 252 patients undergoing aortic valve replacement for bicuspid aortic valve disease by degree of ascending aorta (AA) dilatation. Summary table provides survival estimates (± standard deviation) at 5, 10, and 15 years, respectively. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Survival by decade of aortic valve replacement of 252 patients with bicuspid aortic valve disease. Summary table provides survival estimates (± standard deviation) at 5, 10, and 15 years, respectively. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Survival of 252 patients undergoing aortic valve replacement for bicuspid aortic valve disease by presence or absence of coronary artery disease (CAD). Summary table provides survival estimates (± standard deviation) at 5, 10, and 15 years, respectively. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Risk Factors Associated With Reoperation and Mortality in 252 Patients After Aortic Valve Replacement for Congenitally Bicuspid Aortic Valve Disease "

Similar presentations

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H
Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,
Twenty-Five Year Experience With the St

Twenty-Five Year Experience With the St
High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,
Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 

Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 
Magnitude of Negative Impact of Preoperative Heart Failure on Mortality During Aortic Valve Replacement in the Medicare Population  Christina M. Vassileva,

Magnitude of Negative Impact of Preoperative Heart Failure on Mortality During Aortic Valve Replacement in the Medicare Population  Christina M. Vassileva,
Reply The Annals of Thoracic Surgery

Reply The Annals of Thoracic Surgery
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,
Jiro Esaki, MD, PhD, Bradley G. Leshnower, MD, Jose N

Jiro Esaki, MD, PhD, Bradley G. Leshnower, MD, Jose N
Quality of Life in Patients Undergoing Totally Thoracoscopic Closure for Atrial Septal Defect  Zeng-Shan Ma, MD, PhD, Qiu-Yang Yin, RN, Ming-Feng Dong,

Quality of Life in Patients Undergoing Totally Thoracoscopic Closure for Atrial Septal Defect  Zeng-Shan Ma, MD, PhD, Qiu-Yang Yin, RN, Ming-Feng Dong,
Danny Ramzy, MD, PhD, Alfredo Trento, MD, Wen Cheng, MD, Michele A

Danny Ramzy, MD, PhD, Alfredo Trento, MD, Wen Cheng, MD, Michele A
Ourania Preventza, MD, James J. Livesay, MD, Denton A

Ourania Preventza, MD, James J. Livesay, MD, Denton A
Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.
A 10-Year Experience With the Carbomedics Cardiac Prosthesis

A 10-Year Experience With the Carbomedics Cardiac Prosthesis
Impact of Preoperative Renal Dysfunction on Long-Term Survival for Patients Undergoing Aortic Valve Replacement  Vinod H. Thourani, MD, W. Brent Keeling,

Impact of Preoperative Renal Dysfunction on Long-Term Survival for Patients Undergoing Aortic Valve Replacement  Vinod H. Thourani, MD, W. Brent Keeling,
Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
The Impact of Specific Preoperative Organ Dysfunction in Patients Undergoing Aortic Valve Replacement  Vinod H. Thourani, MD, Ritam Chowdhury, MD, Rebecca.

The Impact of Specific Preoperative Organ Dysfunction in Patients Undergoing Aortic Valve Replacement  Vinod H. Thourani, MD, Ritam Chowdhury, MD, Rebecca.
Suresh Keshavamurthy, MD, Stephanie L

Suresh Keshavamurthy, MD, Stephanie L

Similar presentations

Ads by Google